GENEDX HOLDINGS CORP *W EXP 07/22/202

GENEDX HOLDINGS CORP *W EXP 07/22/202 is a security (CUSIP 81663L119) tracked across SEC portfolio filings. 15 institutional managers reported $25K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $68K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
LMR Partners LLPLONDON, X0$17K2,135,439
D. E. Shaw & Co., Inc.New York, NY$4K467,197
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$2K
TORONTO DOMINION BANKToronto, Ontario, A6$848105,950
WOLVERINE ASSET MANAGEMENT LLCCHICAGO, IL$47158,876
StoneX Group Inc.New York, NY$25932,396
Alpine Global Management, LLCNEW YORK, NY$16020,000
TD Asset Management IncToronto, A6$10134,884
BROWN ADVISORY INCBALTIMORE, MD$8710,833
DUPONT CAPITAL MANAGEMENT CORPWilmington, DE$196,666
WELLS FARGO & COMPANY/MNSAN FRANCISCO, CA$182,200
PRICE T ROWE ASSOCIATES INC /MD/BALTIMORE, MD$2243,780
Q Global Advisors, LLCFORT WORTH, TX$1111,701
Clear Street Group Inc.NEW YORK, NY$1100
CONCOURSE FINANCIAL GROUP SECURITIES, INC.BIRMINGHAM, AL0

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Weiss Strategic Interval FundWeiss Strategic Interval Fund$66K1.29%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$2K0.00%

More